Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

1. Haque, T.
2. Cadenas, F.L.
3. Xicoy, B.
4. Alfonso-Pierola, A.
5. Platzbecker, U.
6. Avivi, I.
7. Brunner, A.M.
8. Chromik, J.
9. Morillo, D.
10. Patel, M.R.
11. Falantes, J.
12. Leitch, H.A.
13. Germing, U.
14. Preis, M.
15. Lenox, L.
16. Lauring, J.
17. Brown, R.J.
18. Kalota, A.
19. Mehta, J.
20. Pastore, F.
21. Gu, J.
22. Mistry, P.
23. Valcárcel, D.